Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Imperial College London
University of Alabama at Birmingham
City of Hope Medical Center
Washington University School of Medicine
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Leap Therapeutics, Inc.
University of Alabama at Birmingham
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Exact Sciences Corporation
Main Line Health
Holy Name Medical Center, Inc.
SpeciCare
Albert Einstein College of Medicine
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Edward-Elmhurst Health System
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center
University of Copenhagen
New Mexico Cancer Research Alliance
Astellas Pharma Inc